Sandford D Smith Cytokinetics Inc (CYTK) insider trading activity

Sandford D Smith is Director of CYTOKINETICS INC. Currently has a direct ownership of 18,801 shares of CYTK, which is worth approximately $937,417. The most recent transaction as insider was on Jan 02, 2024, when has been sold 148 shares (Common Stock) at a price of $84.12 per share, resulting in proceeds of $12,449. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.8K

0% 3M change

0.79% 12M change

Total Value Held $937,417

SANDFORD D SMITH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2024	BUY Grant, award, or other acquisition	$12,449 $84.12 p/Share	148 Added 0.78%	18,801 Common Stock
Oct 02 2023	BUY Grant, award, or other acquisition	$12,490 $27.88 p/Share	448 Added 2.35%	18,653 Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	$12,476 $33.36 p/Share	374 Added 2.01%	18,205 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	-	5,000 Added 21.9%	17,831 Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	$11,237 $37.71 p/Share	298 Added 2.27%	12,831 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	$11,220 $44.35 p/Share	253 Added 1.98%	12,533 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	$5,622 $51.11 p/Share	110 Added 0.89%	12,280 Common Stock
Sep 02 2022	SELL Open market or private sale	$613,585 $53.97 p/Share	11,369 Reduced 48.3%	12,170 Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	$276,267 $24.3 p/Share	11,369 Added 32.57%	23,539 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	$5,617 $41.0 p/Share	137 Added 1.11%	12,170 Common Stock
May 10 2022	BUY Grant, award, or other acquisition	-	5,000 Added 29.35%	12,033 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	$5,603 $38.38 p/Share	146 Added 2.03%	7,033 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	$5,612 $46.0 p/Share	122 Added 1.74%	6,887 Common Stock
Dec 27 2021	SELL Open market or private sale	$1,295,399 $45.79 p/Share	28,290 Reduced 80.7%	6,765 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$578,531 $20.45 p/Share	28,290 Added 72.21%	10,889 Common Stock
Nov 19 2021	SELL Open market or private sale	$1,196,409 $41.21 p/Share	29,032 Reduced 81.1%	6,765 Common Stock
Nov 19 2021	BUY Exercise of conversion of derivative security	$349,255 $12.03 p/Share	29,032 Added 72.89%	10,797 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	$11,242 $36.74 p/Share	306 Added 4.33%	6,765 Common Stock
Jul 19 2021	SELL Open market or private sale	$346,985 $29.0 p/Share	11,965 Reduced 64.94%	6,459 Common Stock
Jul 19 2021	BUY Exercise of conversion of derivative security	$127,786 $10.68 p/Share	11,965 Added 51.08%	11,459 Common Stock
Jul 07 2021	BUY Grant, award, or other acquisition	$1,246 $19.77 p/Share	63 Added 0.97%	6,459 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	$9,986 $20.98 p/Share	476 Added 6.93%	6,396 Common Stock
May 12 2021	BUY Grant, award, or other acquisition	-	5,000 Added 45.79%	5,920 Common Stock
Apr 27 2021	SELL Open market or private sale	$270,257 $27.75 p/Share	9,739 Reduced 91.37%	920 Common Stock
Apr 27 2021	BUY Exercise of conversion of derivative security	$103,428 $10.62 p/Share	9,739 Added 62.19%	5,920 Common Stock

SDS

Sandford D Smith

Director

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account